IUCRO-0042; Blood Drawing for Study of Peripheral Blood T-Lymphocytes and Other Parameters in patients with Metastatic Melanoma and Renal Cell Cancer with Spontaneous Regression
Brief description of study
The purpose of this trial is to collect peripheral blood from patients with metastatic melanoma and renal cell cancer who have experienced spontaneous regression in order to study immune response.
Detailed description of study
The purpose of this study is to collect blood and clinical data from patients with metastatic melanoma and renal cell cancer who have experienced spontaneous regression for studies of immune response and other factors that may influence these occurrences.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Metastatic Melanoma and Renal Cell Carcinoma,Metastatic Melanoma,Renal Cell Carcinoma,Metastatic,Melanoma,Carcinoma,Renal
-
Age: 18 years - 100 years
-
Gender: All
Inclusion Criteria
Patients must have metastatic melanoma or renal cell cancer with spontaneous regression.
Willingness to undergo phlebotomy for research blood samples
Exclusion Criteria
Concurrent disease or condition that would make the patient inappropriate for study participation or any serious medical or psychiatric disorder that would interfere with the subject's safety
Dementia, altered mental status, or any psychiatric condition that would prohibit the understanding or rendering of informed consent
Find a site
,
Send a message
Enter your contact details to connect with study team
Primary Contact
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
Please choose between Voice or SMS based delivery of verification code
or